Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Find value-oriented index funds that maintain low fees in 2024. Understand how value funds can enhance long-term retirement portfolios.
24,728 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Micron Technology races higher on AI memory demand and supply tightness. This piece outlines why investors may consid...
Nvidia’s new AI architectures debuted at GTC 2026, signaling a longer-term AI infrastructure push. Here’s what that m...
A California federal court weighs a landmark supply-chain risk dispute between Anthropic and the Department of War, w...
Dogecoin broke through a multi-session resistance with a heavy volume burst, prompting traders to eye the next hurdle...
Investors are watching Kevin Warsh as a potential Fed chair, weighing policy shifts and market risks as leaders debat...
Regulatory clarity is on the horizon for digital assets as the Clarity Act advances. This guide breaks down three key...
Goldman Sachs warns that real income per worker is dipping despite a robust job market, signaling a hidden squeeze on...
A cybersecurity ETF surged roughly 40% in the last month, signaling a shift in investor sentiment toward AI-enabled d...
A new wave of pet health scares is testing household budgets as four-figure emergency vet bills become the norm, push...
Tensions flare in the Persian Gulf as tit-for-tat attacks continue across the region despite a tentative U.S.-Iran ce...
Sodexo is accelerating AI and robotics across its kitchen operations to cut labor costs, improve menu execution, and ...